Cargando…

Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma

BACKGROUND: Pattern recognition receptors (PRRs) family plays a vital role in the initial stage of innate immune response and the subsequent activation of adaptive immunity. Increasing evidences have indicated that several PRRs play critical roles in the progress of inflammation and tumorigenesis. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qihang, Wang, Qiang, Wang, Tengjiao, Xu, Junfang, Li, Tingting, Liu, Qiuyan, Yao, Qinghua, Wang, Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630683/ https://www.ncbi.nlm.nih.gov/pubmed/34858419 http://dx.doi.org/10.3389/fimmu.2021.765615

Ejemplares similares

Perturbation of Thymocyte Development Underlies the PRRS Pandemic: A Testable Hypothesis
por: Butler, John E., et al.
Publicado: (2019)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic
por: Butler, J. E., et al.
Publicado: (2014)

Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections
por: Kolli, Deepthi, et al.
Publicado: (2013)

Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
por: Tarazona, Raquel, et al.
Publicado: (2016)

The challenge of PRRS immunology
por: Mateu, E., et al.
Publicado: (2008)

Macrophages from naked mole-rat possess distinct immunometabolic signatures upon polarization
por: Gorshkova, Ekaterina A., et al.
Publicado: (2023)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
por: Huang, Fu-xue, et al.
Publicado: (2022)

Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients
por: Li, Zhuoqi, et al.
Publicado: (2023)

Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis
por: Zhao, Jingjing, et al.
Publicado: (2022)

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
por: Gao, Jing, et al.
Publicado: (2022)

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma
por: Li, Hongxia, et al.
Publicado: (2022)

Dynamics and Differences in Systemic and Local Immune Responses After Vaccination With Inactivated and Live Commercial Vaccines and Subsequent Subclinical Infection With PRRS Virus
por: Toman, Miroslav, et al.
Publicado: (2019)

Guía del PRRS : síndrome reproductivo y respiratorio porcino /
por: Ramírez, Alejandro
Publicado: (2015)

Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
por: Li, Hongmu, et al.
Publicado: (2023)

Genetic resistance - an alternative for controlling PRRS?
por: Reiner, Gerald
Publicado: (2016)

Macrophage Recognition of Crystals and Nanoparticles
por: Nakayama, Masafumi
Publicado: (2018)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Molecular Recognition of Gangliosides and Their Potential for Cancer Immunotherapies
por: Krengel, Ute, et al.
Publicado: (2014)

Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm
por: Wang, Tao, et al.
Publicado: (2022)

Breast cancer associated CD169(+) macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
por: Gunnarsdottir, Frida Björk, et al.
Publicado: (2023)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Using a Gene Network of Pyroptosis to Quantify the Responses to Immunotherapy and Prognosis for Neuroblastoma Patients
por: Luo, Bingying, et al.
Publicado: (2022)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Identification of NY-ESO-1(157–165) Specific Murine T Cell Receptors With Distinct Recognition Pattern for Tumor Immunotherapy
por: Zhang, Helin, et al.
Publicado: (2021)

Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy
por: Xiao, Li, et al.
Publicado: (2023)

Economic Analysis of Vaccination Strategies for PRRS Control
por: Linhares, Daniel C. L., et al.
Publicado: (2015)

PRRS: Trans-Atlantic Cooperation and new ideas
por: Dee, S.A.
Publicado: (1996)

Engineering the PRRS virus genome: Updates and perspectives
por: Han, Mingyuan, et al.
Publicado: (2014)

Commercial PRRS Modified-Live Virus Vaccines
por: Chae, Chanhee
Publicado: (2021)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
por: Wang, Zide, et al.
Publicado: (2022)

Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC
por: Wu, Haoming, et al.
Publicado: (2023)

Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs
por: Hao, Chao, et al.
Publicado: (2023)

Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome
por: Yan, Kexin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pqm002v1dn90s83p3g0pifbrc